Distribution of molecules locally delivered from bone cement
Source abstract
Abstract
Abstract Revision of infected orthopedic implants is successful in most cases when antimicrobials are delivered locally (mixed with bone cement or bone graft which is placed in the site from which the infected tissue was removed); however, there is still a substantial rate of recurrence most likely due to the antimicrobials not achieving a therapeutic dose at all locations in the tissue. To study transport within this environment, gadolinium chelated in diethylene triamine pentaacetic acid (Gd‐DTPA), a MRI contrast agent with size and solubility similar to two common antimicrobials (gentamicin and vancomycin), was mixed with bone cement, implanted in vivo into two models of orthopedic surgical wounds, and imaged using MRI 5.5 h after implantation. Image thresholding was used to create two‐dimensional and three‐dimensional representations of areas/volumes containing detectable concentrations of Gd‐DTPA. Distribution is found to be anisotropic with Gd‐DTPA transporting preferentially anterior of the implant toward the skin. When fascia is not closed over the implant site, Gd‐DTPA transports to the skin and along the subcutaneous plane. The distance transported indicates that transport is likely driven by convection. Finally, the tissue concentration of Gd‐DTPA is much less than the concentration loaded into the bone cement. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 806–814, 2014.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Total Knee Arthroplasty Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Interventional Biomaterials, School of Biological and Health Systems Engineering, Arizona State University Tempe Arizona
Banner Good Samaritan Medical Center Phoenix Arizona
References (43)
Show source-provided references
1. 10.1016/j.biomaterials.2005.11.03110.1016/j.biomaterials.2005.11.031 ↗
2. 10.1056/NEJMra03541510.1056/NEJMra035415 ↗
3. 10.1016/j.arth.2010.04.01110.1016/j.arth.2010.04.011 ↗
4. Moss AJ · 1995 · 1
5. 10.1080/1745367061001271910.1080/17453670610012719 ↗
6. 2010
7. Risk factors for surgical site infection in the patient with spinal injury
8. Orthopaedic Practice in the US2010.AAOS Department of Research and Scientific Affairs; Rosemont IL: American Academy of Orthopaedic Surgeons 2011.
9. 10.1016/S0140-6736(01)05321-110.1016/S0140-6736(01)05321-1 ↗
10. 10.1128/JCM.37.6.1771-1776.199910.1128/JCM.37.6.1771-1776.1999 ↗
11. 10.1016/j.injury.2006.04.01510.1016/j.injury.2006.04.015 ↗
12. 10.1590/S1807-5932200700020000210.1590/S1807-59322007000200002 ↗
13. 10.1007/s11999-009-0847-110.1007/s11999-009-0847-1 ↗
14. 10.1016/S0883-5403(99)90061-X10.1016/S0883-5403(99)90061-X ↗
15. 10.1080/1745367061001270010.1080/17453670610012700 ↗
16. 10.3109/1745367090338978210.3109/17453670903389782 ↗
17. 10.1016/j.jconrel.2008.05.02010.1016/j.jconrel.2008.05.020 ↗
18. 10.1007/s11999-010-1324-610.1007/s11999-010-1324-6 ↗
19. 10.1016/S0006-3495(02)75417-910.1016/S0006-3495(02)75417-9 ↗
20. 10.1016/S0006-3495(76)85754-210.1016/S0006-3495(76)85754-2 ↗
21. Release of tobramycin from tobramycin‐containing bone cement in bone and serum of rabbits
22. 10.1302/0301-620X.85B5.1374610.1302/0301-620X.85B5.13746 ↗
23. 10.1097/00003086-199205000-0003710.1097/00003086-199205000-00037 ↗
24. McLaren A · 2000
25. 10.1097/01.blo.0000126303.41711.a210.1097/01.blo.0000126303.41711.a2 ↗
26. 10.1097/00003086-200210000-0000510.1097/00003086-200210000-00005 ↗
27. 10.1016/j.jneumeth.2010.01.00210.1016/j.jneumeth.2010.01.002 ↗
28. 10.3171/foc.2006.20.4.710.3171/foc.2006.20.4.7 ↗
29. 10.1167/iovs.04-009110.1167/iovs.04-0091 ↗
30. 10.1007/s11999-012-2315-610.1007/s11999-012-2315-6 ↗
31. 10.1155/2013/14960810.1155/2013/149608 ↗
32. 10.1006/jmre.2000.221610.1006/jmre.2000.2216 ↗
33. 10.1128/AAC.35.6.125810.1128/AAC.35.6.1258 ↗
34. 10.1021/jo981736610.1021/jo9817366 ↗
35. 10.1007/s11999-009-0847-110.1007/s11999-009-0847-1 ↗
36. 10.1007/s11999-010-1264-110.1007/s11999-010-1264-1 ↗
37. 10.1007/s11999-012-2351-210.1007/s11999-012-2351-2 ↗
38. Haacke EM · 1999
39. 10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O ↗
40. 10.1016/j.mri.2008.04.01110.1016/j.mri.2008.04.011 ↗
41. 10.1097/01.rli.0000184756.66360.d310.1097/01.rli.0000184756.66360.d3 ↗
42. 10.1023/A:101608311312310.1023/A:1016083113123 ↗
43. 10.1016/S0939-6411(01)00198-910.1016/S0939-6411(01)00198-9 ↗